India's Alembic Pharmaceuticals up on FDA approval for seizure treatment tablets

Alembic Pharmaceuticals

03/10/2024 06:10

** Shares of Alembic Pharmaceuticals  ALEM.NS  rise 2.8% to
1,226 rupees
    ** Co gets U.S. FDA's final approval for Lamotrigine
extended release tablets, used for tonic-clonic type of seizures
and partial-onset seizures
    ** Stock eyes a second straight week of gains, if trend
holds
    ** Analysts covering the stock, on avg, have a "hold"
rating; median PT is 1,030 rupees - LSEG data
    ** Stock up ~59% YTD vs a ~38% gain in Nifty Pharma index
 .NIPHARM 

 (Reporting by Yagnoseni Das in Bengaluru)
 ((Yagnoseni.Das@thomsonreuters.com;))